Opinion statement
Various options exist for intestinal interposition for benign, but debilitating, end-stage esophageal disorders. Principally, the stomach, colon, or jejunum is used for esophageal replacement. Much debate exists regarding the ideal esophageal replacement option. The conduit choice must be tailored to the individual patient. Unlike malignant processes, the conduit choice for benign disorders must be sufficiently durable and functional. Colonic interposition meets both criteria. However, this operative procedure’s technical difficulty increases the complexity of this already challenging clinical problem, as seemingly small errors in judgment and technique can significantly impact graft viability and long-term function. Using a gastric tube also provides durability and functionality, but with an operative procedure that is less technically demanding. A minimally invasive laparoscopic transhiatal esophagectomy offers the patient even more benefit in terms of shorter operative times and intensive care unit and recovery periods. However, the advent of surgical robotic technology augments these benefits even further. Robotic technology arms the surgeon with improved dexterity and three-dimensional visualization. These revolutionary improvements allow the surgeon to overcome many of the operative limitations that exist with the open and minimally invasive approaches to esophagectomy, thus potentially offering patients reduced morbidity and mortality rates.
Similar content being viewed by others
References and Recommended Reading
Niemcryk SJ, Joshua-Gotlib S, Levine DS: Outpatient experience of patients with GERD in the United States: analysis of the 1998–2001 National Ambulatory Medical Care Survey. Dig Dis Sci 2005, 50:1904–1908.
Watson TJ, DeMeester TR, Kauer WK, et al.: Esophageal replacement for end-stage benign esophageal disease. J Thorac Cardiovasc Surg 1998, 115:1241–1247; discussion 1247–1249.
Orringer MB, Marshall B, Iannettoni MD: Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg 2001, 25:196–203.
Young MM, Dechamps C, Trastek VF, et al.: Esophageal reconstruction for benign disease: early morbidity, mortality, and functional results. Ann Thorac Surg 2000, 70:1651–1655.
Ferguson DD: Evaluation and management of benign esophageal strictures. Dis Esophagus 2005, 18:359–364.
Repici A, Conio M, De Angelis C, et al.: Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc 2004, 60:513–519.
Schubert D, Kuhn R, Lippert H, Pross M: Endoscopic treatment of benign gastrointestinal anastomotic strictures using argon plasma coagulation in combination with diathermy. Surg Endosc 2003, 17:1579–1582.
Petruzziello L, Costamagna G: Stenting in esophageal strictures. Dig Dis 2002, 20:154–166.
Gupta NM, Gupta R: Transhiatal esophageal resection for corrosive injury. Ann Surg 2004, 239:359–363.
Dimick JB, Wainess RM, Upchurch GR, Jr, et al.: National trends in outcomes for esophageal resection. Ann Thorac Surg 2005, 79:212–216; discussion 217–218.
Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al.: Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003, 238:486–494; discussion 494–495.
Galvani CA, Gorodner MV, Moser F, et al.: Robotically assisted laparoscopic transhiatal esophagectomy. Surg Endosc 2007 [Epub ahead of print.]
Urschel JD: Does the interponat affect outcome after esophagectomy for cancer? Dis Esophagus 2001, 14:124–130.
Mansour KA, Bryan FC, Carlson GW: Bowel interposition for esophageal replacement: twenty-five-year experience. Ann Thorac Surg 1997, 64:752–756.
Renzulli P, Joeris A, Strobel O, et al.: Colon interposition for esophageal replacement: a single-center experience. Langenbecks Arch Surg 2004, 389:128–133.
DeMeester TR, Johannson KE, Franze I, et al.: Indications, surgical technique, and long-term functional results of colon interposition or bypass. Ann Surg 1988, 208:460–474.
Young MM, Deschamps C, Allen MS, et al.: Esophageal reconstruction for benign disease: self-assessment of functional outcome and quality of life. Ann Thorac Surg 2000, 70:1799–1802.
Kirby JD: Quality of life after oesophagectomy: the patients’ perspective. Dis Esophagus 1999, 12:168–171.
Horgan S, Berger RA, Elli EF, Espat NJ: Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 2003, 69:624–626.
Briel JW, Tamhankar AP, Hagen JA, et al.: Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 2004, 198:536–541; discussion 541–542.
Domreis JS, Jobe BA, Aye RW, et al.: Management of long-term failure after colon interposition for benign disease. Am J Surg 2002, 183:544–546.
Thomas P, Fuentes P, Giudicelli R, Reboud E: Colon interposition for esophageal replacement: current indications and long-term function. Ann Thorac Surg 1997, 64:757–764.
Scott-Conner CE: Operations to replace or bypass the esophagus. In Chassin’s Operative Strategy in General Surgery: An Expositive Atlas. Edited by Scott-Conner CE. New York: Springer; 2002:139–150.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bueno, R.S., Galvani, C. & Horgan, S. Intestinal interposition for benign esophageal disease. Curr Treat Options Gastro 11, 43–53 (2008). https://doi.org/10.1007/s11938-008-0006-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11938-008-0006-x